Category Archives: AZBio News
AZBio Honors Ten Arizona Legislators as 2015 Trailblazers
AZBio Trailblazers are selected annually and recognized for their leadership in supporting research, education, innovation and the growth of Arizona’s bioscience sector by the Arizona Bioindustry Association.Continue reading
Flagship launches new website to highlight areas of clinical focus
Flagship Biosciences, the largest tissue image analysis provider for the drug development industry, is pleased to announce a website redesign, which highlights our advanced technology and clinical readiness needed to support image analysis based companion diagnostic strategies for the pharmaceutical industry.Continue reading
AZBio Chairman Takes Home Internationalist Award For Work at Pinnancle Transplant Technologies
Internationalist Award Showcases Pinnacle Transplant Technologies’ Efforts Across Borders
Regenerative medical company working with City of Phoenix and Arizona Commerce Authority, among others, to expand international export opportunities for its innovative allograft productsContinue reading
LabLeaders educational initiative to help redefine the value of the laboratory
First Launched at the AACC 2015 Clinical Lab Expo in August 2015, the Roche LabLeaders educational initiative is designed to help redefine the value of the laboratory with a suite of online and live educational workshops. Continue reading
Protein found in malaria could help stop cancer
Malarial protein binds to a sugar molecule found many types of cancer, enabling anti-cancer drugs to target tumorsContinue reading
Washington Update
The latest updates from Capitol Hill as provided by BIO and Republic Consulting Group.Continue reading
VisionGate graduation from CEI is a big win for Phoenix bioscience community
Bioscience firm VisionGate announces transition to new space in Phoenix Tech Center after graduating from CEI business incubator in OctoberContinue reading
Capstone Therapeutics Announces Allowance of U.S. Patent for Treatment of Diabetes With Apo E Mimetic Peptides
The newly allowed patent expands the utility of the CHAMP technology beyond claims in previous JV patents for the treatment of diabetic dyslipidemia and vascular diseases.Continue reading
Parkinson’s UK and Critical Path Institute Launch the Critical Path for Parkinson’s (CPP) Consortium
Data from past Parkinson’s trials will be collected, standardized, and integrated, in order to inform new approaches to designing clinical trials focused on early-stage Parkinson’s.Continue reading